An 8-week Phase 2 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-assisted-psychotherapy in Adults With Cannabis Use Disorder: A Proof-of-Concept Study
Phase: PHASE2 | Sponsor: McMaster University | Compound: Psilocybin
- Status
- recruiting
- Institution
- McMaster University
- Start date
- 2025-03-01
- End date
- 2026-06-01
- Registry ID
- NCT06225232
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.